Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
A Pharmacogenetic Case-Control Study of Severe Diarrhea and Life-Threatening Neutropenia in Patients Treated With Irinotecan, 5-Fluorouracil and Leucovorin
3 other identifiers
observational
308
3 countries
84
Brief Summary
RATIONALE: Genetic testing may help predict how patients will respond to chemotherapy drugs and may help doctors plan more effective treatment with fewer side effects. PURPOSE: Genetic study to determine how genes affect the severity of diarrhea in patients with stage III colon cancer who are receiving chemotherapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2002
Longer than P75 for all trials
84 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2002
CompletedFirst Submitted
Initial submission to the registry
November 12, 2002
CompletedFirst Posted
Study publicly available on registry
January 27, 2003
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2006
CompletedJuly 6, 2016
July 1, 2016
4.6 years
November 12, 2002
July 1, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
response
Up to 4 years
Study Arms (1)
Group 1
Patients undergo collection of blood specimens for polymerase chain reaction and restriction fragment length polymorphism analysis. Genotyping assays are performed to determine UGT1A1 promoter genotyping, UGT1A1 coding polymorphisms, TS promoter polymorphisms, and MTHFR polymorphisms.
Interventions
Eligibility Criteria
Patients diagnosed with adenocarcinoma of the colon and previously enrolled on CALGB-89803.
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
Study Sites (84)
Northeast Alabama Regional Medical Center
Anniston, Alabama, 36207, United States
Rebecca and John Moores UCSD Cancer Center
La Jolla, California, 92093-0658, United States
Cedars-Sinai Comprehensive Cancer Center at Cedars-Sinai Medical Center
Los Angeles, California, 90048, United States
Veterans Affairs Medical Center - San Diego
San Diego, California, 92161, United States
UCSF Comprehensive Cancer Center
San Francisco, California, 94115, United States
Veterans Affairs Medical Center - San Francisco
San Francisco, California, 94121, United States
CCOP - Christiana Care Health Services
Newark, Delaware, 19713, United States
Lombardi Cancer Center of Georgetown University Medical Center
Washington D.C., District of Columbia, 20007, United States
Walter Reed Army Medical Center
Washington D.C., District of Columbia, 20307-5000, United States
Veterans Affairs Medical Center - Washington, DC
Washington D.C., District of Columbia, 20422, United States
Broward General Medical Center
Fort Lauderdale, Florida, 33316, United States
Memorial Regional Hospital Comprehensive Cancer Center
Hollywood, Florida, 33021, United States
CCOP - Mount Sinai Medical Center
Miami Beach, Florida, 33140, United States
Florida Hospital Cancer Institute
Orlando, Florida, 32804, United States
Palm Beach Cancer Institute
West Palm Beach, Florida, 33401, United States
MBCCOP - University of Illinois at Chicago
Chicago, Illinois, 60612-7323, United States
Veterans Affairs Medical Center - Chicago (Westside Hospital)
Chicago, Illinois, 60612, United States
University of Chicago Cancer Research Center
Chicago, Illinois, 60637-1470, United States
Louis A. Weiss Memorial Hospital
Chicago, Illinois, 60640, United States
West Suburban Center for Cancer Care
River Forest, Illinois, 60305, United States
Saint Anthony Medical Center
Rockford, Illinois, 61108, United States
Fort Wayne Medical Oncology and Hematology, Incorporated
Fort Wayne, Indiana, 46885-5099, United States
CCOP - Northern Indiana CR Consortium
South Bend, Indiana, 46601, United States
Holden Comprehensive Cancer Center at University of Iowa
Iowa City, Iowa, 52242-1009, United States
Baptist Hospital East - Louisville
Louisville, Kentucky, 40207, United States
Marlene and Stewart Greenebaum Cancer Center, University of Maryland
Baltimore, Maryland, 21201, United States
Veterans Affairs Medical Center - Baltimore
Baltimore, Maryland, 21201, United States
Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute
Boston, Massachusetts, 02115, United States
University of Massachusetts Memorial Medical Center - University Campus
Worcester, Massachusetts, 01655, United States
Lakeland Medical Center - St. Joseph
Saint Joseph, Michigan, 49085, United States
Veterans Affairs Medical Center - Minneapolis
Minneapolis, Minnesota, 55417, United States
University of Minnesota Cancer Center
Minneapolis, Minnesota, 55455, United States
Veterans Affairs Medical Center - Columbia (Truman Memorial)
Columbia, Missouri, 65201, United States
Ellis Fischel Cancer Center at University of Missouri - Columbia
Columbia, Missouri, 65203, United States
Barnes-Jewish Hospital
St Louis, Missouri, 63110, United States
Siteman Cancer Center
St Louis, Missouri, 63110, United States
Missouri Baptist Cancer Center
St Louis, Missouri, 63131, United States
University of Nebraska Medical Center
Omaha, Nebraska, 68198-7680, United States
CCOP - Southern Nevada Cancer Research Foundation
Las Vegas, Nevada, 89106, United States
Veterans Affairs Medical Center - Las Vegas
Las Vegas, Nevada, 89106, United States
Norris Cotton Cancer Center at Dartmouth Medical School
Lebanon, New Hampshire, 03756-0002, United States
Cooper University Hospital
Camden, New Jersey, 08103, United States
Veterans Affairs Medical Center - Buffalo
Buffalo, New York, 14215, United States
Roswell Park Cancer Institute
Buffalo, New York, 14263-0001, United States
Elmhurst Hospital Center
Elmhurst, New York, 11373, United States
Queens Cancer Center of Queens Hospital
Jamaica, New York, 11432, United States
CCOP - North Shore University Hospital
Manhasset, New York, 11030, United States
North Shore University Hospital
Manhasset, New York, 11030, United States
Memorial Sloan-Kettering Cancer Center
New York, New York, 10021, United States
New York Weill Cornell Cancer Center at Cornell University
New York, New York, 10021, United States
Mount Sinai Medical Center, NY
New York, New York, 10029, United States
State University of New York - Upstate Medical University
Syracuse, New York, 13210, United States
Veterans Affairs Medical Center - Syracuse
Syracuse, New York, 13210, United States
CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C.
Syracuse, New York, 13217, United States
Veterans Affairs Medical Center - Asheville
Asheville, North Carolina, 28805, United States
Lineberger Comprehensive Cancer Center, UNC
Chapel Hill, North Carolina, 27599-7295, United States
NorthEast Oncology Associates
Concord, North Carolina, 28025, United States
Veterans Affairs Medical Center - Durham
Durham, North Carolina, 27705, United States
Duke Comprehensive Cancer Center
Durham, North Carolina, 27710, United States
Cape Fear Valley Health System
Fayetteville, North Carolina, 28302-2000, United States
Lenoir Memorial Hospital Cancer Center
Kinston, North Carolina, 28503-1678, United States
FirstHealth Moore Regional Hospital
Pinehurst, North Carolina, 28374, United States
New Hanover Regional Medical Center
Wilmington, North Carolina, 28402-9025, United States
CCOP - Southeast Cancer Control Consortium
Winston-Salem, North Carolina, 27104-4241, United States
Comprehensive Cancer Center at Wake Forest University
Winston-Salem, North Carolina, 27157-1082, United States
Veterans Affairs Medical Center - Fargo
Fargo, North Dakota, 58102, United States
Arthur G. James Cancer Hospital - Ohio State University
Columbus, Ohio, 43210-1240, United States
CCOP - Geisinger Clinic and Medical Center
Danville, Pennsylvania, 17822-2001, United States
Western Pennsylvania Hospital
Pittsburgh, Pennsylvania, 15224, United States
Lifespan: The Miriam Hospital
Providence, Rhode Island, 02906, United States
Veterans Affairs Medical Center - Dallas
Dallas, Texas, 75216, United States
Simmons Cancer Center at University of Texas Southwestern Medical Center - Dalas
Dallas, Texas, 75235-9154, United States
Green Mountain Oncology Group
Bennington, Vermont, 05201, United States
Vermont Cancer Center at University of Vermont
Burlington, Vermont, 05401-3498, United States
Veterans Affairs Medical Center - White River Junction
White River Junction, Vermont, 05009, United States
Martha Jefferson Hospital
Charlottesville, Virginia, 22902, United States
Virginia Oncology Associates - Norfolk
Norfolk, Virginia, 23502, United States
MBCCOP - Massey Cancer Center
Richmond, Virginia, 23298-0037, United States
Oncology and Hematology Associates of Southwest Virginia, Inc.
Roanoke, Virginia, 24014, United States
St. Mary's Medical Center
Huntington, West Virginia, 25701, United States
CCOP - St. Vincent Hospital Cancer Center, Green Bay
Green Bay, Wisconsin, 54301, United States
Ministry Medical Group - Northern Region
Rhinelander, Wisconsin, 54501, United States
McGill University
Montreal, Quebec, H2W 1S6, Canada
University of Puerto Rico School of Medicine Medical Sciences Campus
San Juan, Puerto Rico, 00936-5067, Puerto Rico
Biospecimen
blood specimens
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Mark J. Ratain, MD
University of Chicago
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 12, 2002
First Posted
January 27, 2003
Study Start
April 1, 2002
Primary Completion
November 1, 2006
Study Completion
November 1, 2006
Last Updated
July 6, 2016
Record last verified: 2016-07